Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 8, 2008, Pages 491-498

  Brennan, Ellen P ^a,b   Tang, Xiao Han ^d   Stewart Akers, Ann M ^b   Gudas, Lorraine J ^d   Badylak, Stephen F ^b,c  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell recruitment; Chemotaxis; Degradation; Extracellular matrix; Keratinocyte; Scaffold

Indexed keywords

CYTOLOGY; DEGRADATION; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE;

CELL RECRUITMENT; CHEMOATTRACTANTS; CHEMOTAXI; DEGRADATION PRODUCTS; EXTRACELLULAR MATRICES; HUMAN KERATINOCYTE; HUMAN SKIN; KERATINOCYTES; PROGENITOR CELL; STEM-CELL;

BIOCHEMISTRY;

CHEMOATTRACTANT; PEPSIN A; CHEMOTACTIC FACTOR;

ARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KERATINOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STEM CELL; ADULT; CELL CULTURE; CHEMOTAXIS; CYTOLOGY; DRUG EFFECT; FETUS; FLUORESCENCE MICROSCOPY; METABOLISM; SKIN;

ADULT; CELLS, CULTURED; CHEMOTACTIC FACTORS; CHEMOTAXIS; EXTRACELLULAR MATRIX; FETUS; HUMANS; KERATINOCYTES; MICROSCOPY, FLUORESCENCE; PEPSIN A; SKIN; STEM CELLS;

EID: 64049094754     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.123     Document Type: Article

References (66)

1. Adzick N, Longaker MT (eds). 1992; Fetal Wound Healing. Elsevier Scientific: New York.
2. Ambesi A, Klein RM. 2005; Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells. Cancer Res 65(1): 148-156. (Pubitemid 40070805)
3. Atala A. 2002; Experimental and clinical experience with tissue engineering techniques for urethral reconstruction. Urol Clin North Am 29(2): 485-492, ix.
4. Badylak SF, Meurling S, Chen M, et al. 2000; Resorbable bioscaffold for esophageal repair in a dog model. J Pediatr Surg 35(7): 1097-1103. (Pubitemid 30432198)
5. Badylak SF, Obermiller J, Geddes L, et al. 2003; Extracellular matrix for myocardial repair. Heart Surg Forum 6(2): E20-26.
6. Badylak SF. 2002; The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 13(5): 377-383.
7. Badylak SF. 2004; Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 12(3-4): 367-377. (Pubitemid 38639730)
8. Badylak SF, Coffey AC, Lantz GC, et al. 1994; Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. J Vasc Surg 19(3): 465-472.
9. Badylak SF, Kropp B, McPherson T, et al. 1998; Small intestional submucosa: a rapidly resorbed bioscaffold for augmentation cystoplasty in a dog model. Tissue Eng 4(4): 379-387. (Pubitemid 28553525)
10. Badylak SF, Lantz GC, Coffey A, et al. 1989; Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 47(1): 74-80. (Pubitemid 19183414)
11. Badylak SF, Park K, Peppas N, et al. 2001; Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp Hematol 29(11): 1310-1318. (Pubitemid 33033308)
12. Badylak SF, Tullius R, Kokini K, et al. 1995; The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J Biomed Mater Res 29(8): 977-985.
13. Badylak SF, Vorp DA, Spievack AR, et al. 2005; Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 128(1): 87-97.
14. Badylak SF, Wu CC, Bible M, et al. 2003; Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair. J Biomed Mater Res B Appl Biomater 67(1): 648-654. (Pubitemid 37517117)
15. Beattie AJ, Gilbert TW, Guyot JP, et al. In press. Chemoattraction of progenitor cells by remodelling extracellular matrix scaffolds. Tissue Eng.
16. Brennan EP, Reing J, Chew D, et al. 2006; Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 12(10): 2949-2955. (Pubitemid 46150658)
17. Brittan M, Wright NA. 2002; Gastrointestinal stem cells. J Pathol 197(4): 492-509.
18. Brivanlou AH, Gage FH, Jaenisch R, et al. 2003; Stem cells. Setting standards for human embryonic stem cells. Science 300(5621): 913-916.
19. Brown B, Lindberg K, Reing J, et al. 2006; The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 12(3): 519-526. (Pubitemid 43673457)
20. Bullard KM, Longaker MT, Lorenz HP, et al. 2003; Fetal wound healing: current biology. World J Surg 27(1): 54-61. (Pubitemid 36920185)
21. Chen WY, Abatangelo G. 1999; Functions of hyaluronan in wound repair. Wound Repair Regen 7(2): 79-89.
22. Cotsarelis G. 2006; Epithelial stem cells: a folliculocentric view. J Invest Dermatol 126(7): 1459-1468. (Pubitemid 43910361)
23. Crisan M, Yap S, Casteilla L, et al. 2008; A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3): 301-313.
24. Dahms SE, Piechota HJ, Nunes L, et al. 1997; Free ureteral replacement in rats: regeneration of ureteral wall components in the acellular matrix graft. Urology 50(5): 818-825. (Pubitemid 27495013)
25. Deed R, Rooney P, Kumar P, et al. 1997; Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 71(2): 251-256. (Pubitemid 27252999)
26. Dejardin LM, Arnoczky SP, Clarke RB, et al. 1999; Use of small intestinal submucosal implants for regeneration of large fascial defects: an experimental study in dogs. J BiomedMater Res 46(2): 203-211. (Pubitemid 129513743)
27. Gilbert TW, Stewart-Akers AM, Badylak SF, et al. 2007; A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 28(2): 147-150.
28. Gilbert TW, Stolz DB, Biancaniello F, et al. 2005; Production and characterization of ECM powder: implications for tissue engineering applications. Biomaterials 26(12): 1431-1435.
29. Gimble JM, Katz AJ, Bunnell BA, et al. 2007; Adipose-derived stem cells for regenerative medicine. Circ Res 100(9): 1249-1260.
30. Herrera MB, Bruno S, Buttiglieri S, et al. 2006; Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24(12): 2840-2850.
31. Holtom PD, Shinar Z, Benna J, et al. 2004; Porcine small intestine submucosa does not show antimicrobial properties. Clin Orthop Relat Res 427: 18-21.
32. Illingworth CM. 1974; Trapped fingers and amputated finger tips in children. J Pediatr Surg 9(6): 853-858.
33. Janes SM, Lowell S, Hutter C, et al. 2002; Epidermal stem cells. J Pathol 197(4): 479-491.
34. Jensen UB, Lowell S, Watt FM, et al. 1999; The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based onwhole-mount labelling and lineage analysis. Development 126(11): 2409-2418.
35. Jones PH, Harper S, Watt FM, et al. 1995; Stem cell patterning and fate in human epidermis. Cell 80(1): 83-93.
36. Kim CF, Jackson EL, Woolfenden AE, et al. 2005; Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6): 823-835.
37. Kropp BP, Eppley BL, Prevel CD, et al. 1995; Experimental assessment of small intestinal submucosa as a bladder wall substitute. Urology 46(3): 396-400.
38. Kropp BP, Rippy MK, Badylak SF, et al. 1996; Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations. J Urol 155(6): 2098-2104.
39. Larouche D, Hayward C, Cuffley K, et al. 2005; Keratin 19 as a stem cell marker in vivo and in vitro. Methods Mol Biol 289: 103-110.
40. Levy V, Lindon C, Zheng Y, et al. 2007; Epidermal stem cells arise from the hair follicle after wounding. FASEB J 21(7): 1358-1366.
41. Li F, Li W, Johnson S, et al. 2004; Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 11(3-4): 199-206.
42. Lyle S, Christofidou-Solomidou M, Liu Y, et al. 1999; Human hair follicle bulge cells are biochemically distinct and possess an epithelial stem cell phenotype. J Investig Dermatol Symp Proc 4(3): 296-301.
43. Mimeault M, Hauke R, Batra SK, et al. 2007; Stem cells: a revolution in therapeutics - recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82(3): 252-264.
44. Mongan NP, Martin KM, Gudas LJ, et al. 2006; The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog 45(12): 887-900.
45. Moore KA, Lemischka IR. 2006; Stem cells and their niches. Science 311(5769): 1880-1885.
46. Mott JD, Werb Z. 2004; Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16(5): 558-564.
47. Ortega N, Werb Z. 2002; New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci 115(22): 4201-4214.
48. Peault B, Rudnicki M, Torrente Y, et al. 2007; Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15(5): 867-877.
49. Ponce ML, Hibino S, Lebioda AM, et al. 2003; Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth. Cancer Res 63(16): 5060-5064.
50. Ramchandran R, Dhanabal M, Volk R, et al. 1999; Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255(3): 735-739.
51. Record RD, Hillegonds D, Simmons C, et al. 2001; In vivo degradation of 14C-labelled small intestinal submucosa (SIS) when used for urinary bladder repair. Biomaterials 22(19): 2653-2659.
52. Reing JE, Zhang L, Myers-Irvin J, et al. In press. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng.
53. Richards M, Tan SP, Tan JH, et al. 2004; The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22(1): 51-64.
54. Roh C, Lyle S. 2006; Cutaneous stem cells and wound healing. Pediatr Res 59(4, pt 2): R 100-103.
55. Sarikaya A, Record R, Wu CC, et al. 2002; Antimicrobial activity associated with extracellular matrices. Tissue Eng 8(1): 63-71.
56. Schenk S, Quaranta V. 2003; Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 13(7): 366-375.
57. Sellaro TL, Ravindra AK, Stolz DB, et al. 2007; Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng 13(9): 2301-2310.
58. Shell DH IV, Croce MA, Cagiannos C, et al. 2005; Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of Gram-positive contamination. Ann Surg 241(6): 995-1001; discussion, 1001-1004.
59. Slevin M, Kumar S, Gaffney J, et al. 2002; Angiogenic oligosaccharides of hyaluronan induce multiple signalling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 277(43): 41046-41059.
60. Vaananen HK. 2005; Mesenchymal stem cells. Ann Med 37(7): 469-479.
61. Vaught JD, Kropp BP, Sawyer BD, et al. 1996; Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: functional innervation and receptor expression. J Urol 155(1): 374-378.
62. Werb Z, Chin JR. 1998; Extracellular matrix remodelling during morphogenesis. Ann N Y Acad Sci 857: 110-118.
63. Wilson A, Trumpp A. 2006; Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6(2): 93-106.
64. Xu J, Rodriguez D, Petitclerc E, et al. 2001a; Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154(5): 1069-1079. (Pubitemid 34286185)
65. Xu R, Yao ZY, Xin L, et al. 2001b; NC1 domain of human type VIII collagen (α1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem Biophys Res Commun 289(1): 264-268. (Pubitemid 33108825)
66. Zantop T, Gilbert TW, Yoder MC, et al. 2006; Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of Achilles tendon reconstruction. J Orthop Res 24(6): 1299-1309. (Pubitemid 43870893)